Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statement

European Respiratory Journal 2026

View at publisher
Authors: Ashley Fraser, Ling-Ling Tsai, Caitlin C. Fermoyle, Nathan Mortimer, Lauren K. Troy, John A. Mackintosh, Daniel Charles Chambers, Nicole S L Goh, David G. Milne, Jeremy P. Wrobel, MARGARET L. WILSHER, Sally de Boer
+6 more Matthew J S Parker, Susanne E. Webster, Amy Baker, Tania Hyde, Jennifer Ailsey Alison, Tamera J. Corte
DOI: 10.1183/13993003.01987-2025
Cited by: 0
References: 4

Abstract

Extract We commend Ryerson et al. [1] and the assembled multinational expert panel for the recently published “Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement”. The classification represents a major global collaborative effort in the refinement and standardisation of interstitial lung disease (ILD) taxonomy.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Chronic Obstructive Pulmonary Disease (COPD) Research Sarcoidosis and Beryllium Toxicity Research

Publication details

Journal / source
European Respiratory Journal
Volume
67
Issue
1
Pages
2501987–2501987
Publication date
1 January 2026
Language
EN